These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24900729)

  • 1. Patent portfolios after myriad, how to fit in those new genes?
    Aceto JF
    ACS Med Chem Lett; 2013 Aug; 4(8):681-3. PubMed ID: 24900729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
    Kumamoto A; Schmid CL
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).
    Gordon J
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patenting Nucleic Acid Sequences: More Ambiguity from the High Court?
    Lawson C
    J Law Med; 2018 Apr; 25(3):741-764. PubMed ID: 29978665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patenting nature-a comparative perspective.
    Dreyfuss RC; Nielsen J; Nicol D
    J Law Biosci; 2018 Dec; 5(3):550-589. PubMed ID: 31143455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?
    Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS
    Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dolly and
    Burk DL
    J Law Biosci; 2015 Nov; 2(3):606-626. PubMed ID: 27774214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
    Komatani TS
    Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
    [No Abstract]   [Full Text] [Related]  

  • 13. MYRIAD VOICES AGAINST GENE PATENTS IN THE HIGH COURT.
    McCallum L; Faunce T
    J Law Med; 2015 Dec; 23(2):322-9. PubMed ID: 26939499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patentability of genetically engineered microorganisms.
    Cooper A
    JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mayo v. Prometheus: A Year Later.
    Dorn BR
    ACS Med Chem Lett; 2013 Jul; 4(7):572-3. PubMed ID: 24900711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myriad and its implications for patent protection of isolated natural products in the United States.
    Wong AY; Chan AW
    Chin Med; 2014; 9():17. PubMed ID: 25006347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The History of Patenting Genetic Material.
    Sherkow JS; Greely HT
    Annu Rev Genet; 2015; 49():161-82. PubMed ID: 26442843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continental drift? Do European clinical genetic testing laboratories have a patent problem?
    Liddicoat J; Liddell K; McCarthy AH; Hogarth S; Aboy M; Nicol D; Patton S; Hopkins MM
    Eur J Hum Genet; 2019 Jul; 27(7):997-1007. PubMed ID: 30846855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent law--man-made, living microorganisms held patentable subject matter under section 101 of the Patent Act--Diamond v. Chakrabarty, 447 U.S. 303 (1980).
    Faggen N
    Temple Law Q; 1981; 54(2):308-30. PubMed ID: 11652407
    [No Abstract]   [Full Text] [Related]  

  • 20. Court lifts ban on enforcing Miss. anti-abortion law.
    Denniston L
    Sun; 1992 Aug; ():3A. PubMed ID: 12286287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.